Picture of HH Biotechnology Holdings Co logo

HHBT HH Biotechnology Holdings Co Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro Cap

Annual cashflow statement for HH Biotechnology Holdings Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

C2011
December 31st
2012
December 31st
2013
December 31st
2014
December 31st
2015
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line3.19-2.33-1.81-4.312.42
Depreciation
Non-Cash Items-4.9100.0992.78-2.23
Other Non-Cash Items
Changes in Working Capital0.015-0.220.076-0.0480.162
Change in Accounts Receivable
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities1.590.7661.691.693.57
Capital Expenditures-0.001-0.012-0.017-0.001-0.042
Purchase of Fixed Assets
Other Investing Cash Flow Items0
Sale of Fixed Assets
Cash from Investing Activities-0.001-0.012-0.017-0.001-0.042
Financing Cash Flow Items0.6510
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-5.13-1.11-0.6260.162-2.47
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-3.29-0.3671.191.681.02